Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Rose

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
The Lancet. Neurology|February 19, 2010
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon betaDaniel Wynn, Michael Kaufman, Xavier Montalban, et al.
Journal of Neurology|May 6, 2011
Vascular function and multiple sclerosisAnette S Fjeldstad, John McDaniel, Melissa A H Witman, et al.
Multiple Sclerosis and Related Disorders|October 23, 2017
Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosisJohn W Rose, Gavin Giovannoni, Heinz Wiendl, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|September 17, 2016
Characterization of spinal cord white matter by suppressing signal from hindered space. A Monte Carlo simulation and an ex vivo ultrahigh-b diffusion-weighted imaging studyNabraj Sapkota, Sook Yoon, Bijaya Thapa, et al.
Frontiers in Neurology|June 26, 2023
Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experienceYoji Hoshina, Ka-Ho Wong, Jonathan Galli, et al.
Journal of Neuroimmunology|November 3, 2009
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseasesJohannes Brettschneider, Troy D Jaskowski, Hayrettin Tumani, et al.
Journal of the American Chemical Society|September 11, 2024
An Integrated Experimental and Modeling Approach for Assessing High-Temperature Decomposition Kinetics of ExplosivesVirginia W Manner, Marc J Cawkwell, Kyle D Spielvogel, et al.
JMIR Research Protocols|June 24, 2026
Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design ApproachClaudia Gambrah-Lyles, Aaron W Abrams, Sara Loud, et al.
Clinical Neurology and Neurosurgery|August 30, 2021
Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSFLinda A Villani, Eric L Stulberg, Justin R Abbatemarco, et al.
Pediatric Neurology|December 28, 2023
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder SurveyClaudia Gambrah-Lyles, Varun Kannan, Tim Lotze, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
The Lancet. Neurology|February 19, 2010
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon betaDaniel Wynn, Michael Kaufman, Xavier Montalban, et al.
Journal of Neurology|May 6, 2011
Vascular function and multiple sclerosisAnette S Fjeldstad, John McDaniel, Melissa A H Witman, et al.
Multiple Sclerosis and Related Disorders|October 23, 2017
Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosisJohn W Rose, Gavin Giovannoni, Heinz Wiendl, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|September 17, 2016
Characterization of spinal cord white matter by suppressing signal from hindered space. A Monte Carlo simulation and an ex vivo ultrahigh-b diffusion-weighted imaging studyNabraj Sapkota, Sook Yoon, Bijaya Thapa, et al.
Frontiers in Neurology|June 26, 2023
Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experienceYoji Hoshina, Ka-Ho Wong, Jonathan Galli, et al.
Journal of Neuroimmunology|November 3, 2009
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseasesJohannes Brettschneider, Troy D Jaskowski, Hayrettin Tumani, et al.
Journal of the American Chemical Society|September 11, 2024
An Integrated Experimental and Modeling Approach for Assessing High-Temperature Decomposition Kinetics of ExplosivesVirginia W Manner, Marc J Cawkwell, Kyle D Spielvogel, et al.
JMIR Research Protocols|June 24, 2026
Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design ApproachClaudia Gambrah-Lyles, Aaron W Abrams, Sara Loud, et al.
Clinical Neurology and Neurosurgery|August 30, 2021
Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSFLinda A Villani, Eric L Stulberg, Justin R Abbatemarco, et al.
Pediatric Neurology|December 28, 2023
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder SurveyClaudia Gambrah-Lyles, Varun Kannan, Tim Lotze, et al.
Pageof 7